Accordingly, Voest’s group generated tumor-reactive CD4+ and CD8+ T lymphocytes by co-culturing autologous PBMCs with colorectal cancer or NSCLC PDOs, in medium supplemented with IL-2, anti-CD28, and anti-PD1 (195, 205). The gene discussed is CD8A; the disease is non-small cell lung carcinoma.